Sacyr SA (SCYR.MC) stock: key figures, P/E, revenue and dividend
Industrials · Spain · ISIN ES0182870214
Sacyr SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.57 bn EUR | 4.66 bn EUR |
| Gross profit | 3.12 bn EUR | 758.00 m EUR |
| Operating income | 1.21 bn EUR | 1.08 bn EUR |
| EBIT | 1.23 bn EUR | 1.09 bn EUR |
| Net income | 113.00 m EUR | 85.00 m EUR |
| Diluted EPS – continuing operations | 0.15 EUR | 0.11 EUR |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sacyr SA
Sacyr, S.A. engages in the development and operation of infrastructure concessions worldwide. It is involved in the infrastructure development, such as transportation, sanitation, water, and waste treatment; development of large-scale civil engineering, industrial transport infrastructure, and building projects; water treatment, purification, desalination, purification, and reuse, as well as operation and maintenance of facilities. The company was formerly known as Sacyr Vallehermoso S.A. and changed its name to Sacyr, S.A. in August 2013. Sacyr, S.A. is based in Madrid, Spain.
More stocks
- Tango Therapeutics, Inc. (TNGX)
- Ermenegildo Zegna NV (ZGN)
- KT Corporation (KT)
- HICL Infrastructure PLC (HICL.L)
- Jiangsu Hoperun Software Co Ltd (300339.SZ)
- T&S Communications Co Ltd (300570.SZ)
- Kinik Co (1560.TW)
- Trina Solar Co Ltd (688599.SS)
- Pacific Securities Co Ltd (601099.SS)
- Vidrala SA (VID.MC)
- Dormakaba Holding AG (DOKA.SW)
- Xenon Pharmaceuticals Inc. (XENE)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.